Differentiation of Adipose Tissue–Derived CD34+/CD31− Cells into Endothelial Cells In Vitro

Anoosha Forghani, Srinivas Koduru, Cong Chen, Ashley N. Leberfinger, Dino Ravnic, Daniel J. Hayes

Research output: Contribution to journalArticle

Abstract

Abstract: In this study, CD34 + /CD31 progenitor cells were isolated from the stromal vascular fraction (SVF) of adipose tissue using magnetic activated cell sorting. The endothelial differentiation capability of these cells in vitro was evaluated by culturing them in vascular endothelial growth factor (VEGF)–induced medium for 14 days. Viability, proliferation, differentiation, and tube formation of these cells were evaluated. Cell viability study revealed that both undifferentiated and endothelial-differentiated cells remained healthy for 14 days. However, the proliferation rate was higher in undifferentiated cells compared to endothelial-differentiated ones. Upregulation of endothelial characteristic genes (von Willebrand factor (vWF) and VE-cadherin) was observed in 2D culture. However, PECAM (CD31) was only found to be upregulated after the cells had formed tube-like structures in 3D Matrigel culture. These results indicate that adipose-derived CD34 + /CD31 cells when cultured in VEGF-induced medium, are capable differentiation into endothelial-like lineages. Tube formation of the cells started 3 h after seeding the cells on Matrigel and formed more stable and connected network 24 h post-seeding in presence of VEGF. Lay Summary: In this work, endothelial differentiation capability of CD34 + /CD31 cells isolated from adipose tissue was evaluated. The results showed that these cells can be successfully differentiated into endothelial cells in vitro in the presence of VEGF. Vascularization is crucial for the survival of the cells and formation of new tissues in engineered tissue constructs. Therefore, finding a proper source of progenitor cells capable of endothelial differentiation is of substantial importance in tissue engineering for the vascularization of large-volume complex tissues. CD34 + /CD31 cells can be easily harvested from adipose tissues in abundance unlike other mesenchymal stem cells such as bone marrow stem cells, which makes them advantageous for vascularization in tissue engineering.

Original languageEnglish (US)
JournalRegenerative Engineering and Translational Medicine
DOIs
StatePublished - Jan 1 2019

Fingerprint

Endothelial cells
Endothelial Cells
Tissue
Vascular Endothelial Growth Factor A
Cells
Stem cells
Tissue engineering
Adipose Tissue
Tissue Engineering
Cell Survival
von Willebrand Factor
Stem Cells
Sorting
In Vitro Techniques
Bone
Genes
Mesenchymal Stromal Cells
Bone Marrow Cells
Blood Vessels
Intercellular Signaling Peptides and Proteins

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cell Biology

Cite this

@article{851d612c379343f489207c674c8abceb,
title = "Differentiation of Adipose Tissue–Derived CD34+/CD31− Cells into Endothelial Cells In Vitro",
abstract = "Abstract: In this study, CD34 + /CD31 − progenitor cells were isolated from the stromal vascular fraction (SVF) of adipose tissue using magnetic activated cell sorting. The endothelial differentiation capability of these cells in vitro was evaluated by culturing them in vascular endothelial growth factor (VEGF)–induced medium for 14 days. Viability, proliferation, differentiation, and tube formation of these cells were evaluated. Cell viability study revealed that both undifferentiated and endothelial-differentiated cells remained healthy for 14 days. However, the proliferation rate was higher in undifferentiated cells compared to endothelial-differentiated ones. Upregulation of endothelial characteristic genes (von Willebrand factor (vWF) and VE-cadherin) was observed in 2D culture. However, PECAM (CD31) was only found to be upregulated after the cells had formed tube-like structures in 3D Matrigel culture. These results indicate that adipose-derived CD34 + /CD31 − cells when cultured in VEGF-induced medium, are capable differentiation into endothelial-like lineages. Tube formation of the cells started 3 h after seeding the cells on Matrigel and formed more stable and connected network 24 h post-seeding in presence of VEGF. Lay Summary: In this work, endothelial differentiation capability of CD34 + /CD31 − cells isolated from adipose tissue was evaluated. The results showed that these cells can be successfully differentiated into endothelial cells in vitro in the presence of VEGF. Vascularization is crucial for the survival of the cells and formation of new tissues in engineered tissue constructs. Therefore, finding a proper source of progenitor cells capable of endothelial differentiation is of substantial importance in tissue engineering for the vascularization of large-volume complex tissues. CD34 + /CD31 − cells can be easily harvested from adipose tissues in abundance unlike other mesenchymal stem cells such as bone marrow stem cells, which makes them advantageous for vascularization in tissue engineering.",
author = "Anoosha Forghani and Srinivas Koduru and Cong Chen and Leberfinger, {Ashley N.} and Dino Ravnic and Hayes, {Daniel J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s40883-019-00093-7",
language = "English (US)",
journal = "Regenerative Engineering and Translational Medicine",
issn = "2364-4133",
publisher = "Springer International Publishing AG",

}

TY - JOUR

T1 - Differentiation of Adipose Tissue–Derived CD34+/CD31− Cells into Endothelial Cells In Vitro

AU - Forghani, Anoosha

AU - Koduru, Srinivas

AU - Chen, Cong

AU - Leberfinger, Ashley N.

AU - Ravnic, Dino

AU - Hayes, Daniel J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Abstract: In this study, CD34 + /CD31 − progenitor cells were isolated from the stromal vascular fraction (SVF) of adipose tissue using magnetic activated cell sorting. The endothelial differentiation capability of these cells in vitro was evaluated by culturing them in vascular endothelial growth factor (VEGF)–induced medium for 14 days. Viability, proliferation, differentiation, and tube formation of these cells were evaluated. Cell viability study revealed that both undifferentiated and endothelial-differentiated cells remained healthy for 14 days. However, the proliferation rate was higher in undifferentiated cells compared to endothelial-differentiated ones. Upregulation of endothelial characteristic genes (von Willebrand factor (vWF) and VE-cadherin) was observed in 2D culture. However, PECAM (CD31) was only found to be upregulated after the cells had formed tube-like structures in 3D Matrigel culture. These results indicate that adipose-derived CD34 + /CD31 − cells when cultured in VEGF-induced medium, are capable differentiation into endothelial-like lineages. Tube formation of the cells started 3 h after seeding the cells on Matrigel and formed more stable and connected network 24 h post-seeding in presence of VEGF. Lay Summary: In this work, endothelial differentiation capability of CD34 + /CD31 − cells isolated from adipose tissue was evaluated. The results showed that these cells can be successfully differentiated into endothelial cells in vitro in the presence of VEGF. Vascularization is crucial for the survival of the cells and formation of new tissues in engineered tissue constructs. Therefore, finding a proper source of progenitor cells capable of endothelial differentiation is of substantial importance in tissue engineering for the vascularization of large-volume complex tissues. CD34 + /CD31 − cells can be easily harvested from adipose tissues in abundance unlike other mesenchymal stem cells such as bone marrow stem cells, which makes them advantageous for vascularization in tissue engineering.

AB - Abstract: In this study, CD34 + /CD31 − progenitor cells were isolated from the stromal vascular fraction (SVF) of adipose tissue using magnetic activated cell sorting. The endothelial differentiation capability of these cells in vitro was evaluated by culturing them in vascular endothelial growth factor (VEGF)–induced medium for 14 days. Viability, proliferation, differentiation, and tube formation of these cells were evaluated. Cell viability study revealed that both undifferentiated and endothelial-differentiated cells remained healthy for 14 days. However, the proliferation rate was higher in undifferentiated cells compared to endothelial-differentiated ones. Upregulation of endothelial characteristic genes (von Willebrand factor (vWF) and VE-cadherin) was observed in 2D culture. However, PECAM (CD31) was only found to be upregulated after the cells had formed tube-like structures in 3D Matrigel culture. These results indicate that adipose-derived CD34 + /CD31 − cells when cultured in VEGF-induced medium, are capable differentiation into endothelial-like lineages. Tube formation of the cells started 3 h after seeding the cells on Matrigel and formed more stable and connected network 24 h post-seeding in presence of VEGF. Lay Summary: In this work, endothelial differentiation capability of CD34 + /CD31 − cells isolated from adipose tissue was evaluated. The results showed that these cells can be successfully differentiated into endothelial cells in vitro in the presence of VEGF. Vascularization is crucial for the survival of the cells and formation of new tissues in engineered tissue constructs. Therefore, finding a proper source of progenitor cells capable of endothelial differentiation is of substantial importance in tissue engineering for the vascularization of large-volume complex tissues. CD34 + /CD31 − cells can be easily harvested from adipose tissues in abundance unlike other mesenchymal stem cells such as bone marrow stem cells, which makes them advantageous for vascularization in tissue engineering.

UR - http://www.scopus.com/inward/record.url?scp=85062970153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062970153&partnerID=8YFLogxK

U2 - 10.1007/s40883-019-00093-7

DO - 10.1007/s40883-019-00093-7

M3 - Article

AN - SCOPUS:85062970153

JO - Regenerative Engineering and Translational Medicine

JF - Regenerative Engineering and Translational Medicine

SN - 2364-4133

ER -